Cargando…
Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
BACKGROUND: Immunotherapy has revolutionized the clinical outcomes of intractable cancer patients. Little is known about the intestinal nonpathogenic bacterial composition of hepatocellular carcinoma (HCC) patients treated by immunotherapy. AIM: To determine whether there is a correlation between gu...
Autores principales: | Chung, Min-Woo, Kim, Moon-Ju, Won, Eun Jeong, Lee, Yu Jeong, Yun, Yong-Woon, Cho, Sung Bum, Joo, Young-Eun, Hwang, Jun-Eul, Bae, Woo Kyun, Chung, Ik-Joo, Shin, Myung Geun, Shin, Jong Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611200/ https://www.ncbi.nlm.nih.gov/pubmed/34876793 http://dx.doi.org/10.3748/wjg.v27.i42.7340 |
Ejemplares similares
-
Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012) -
Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
por: Hwang, Jun-Eul, et al.
Publicado: (2010) -
Benefits of Adjuvant Chemotherapy for Clinical T3-4N0 Rectal Cancer After Preoperative Chemoradiotherapy
por: Bang, Hyun Jin, et al.
Publicado: (2023) -
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012) -
Hepatic arterial infusion chemotherapy versus systemic therapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Kim, Hyeon-Jong, et al.
Publicado: (2023)